Steve E. Krognes, CFO and Treasurer at Denali Therapeutics Inc. (DNLI), sold 4,450 shares at $44.75 ($199K) on 2022-01-05, disclosed to the SEC on 2022-01-07.
Open-market sale of $199k DNLI by CFO and Treasurer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $44.75 | 2,225 | $100K | 50.0% |
| 2 | $44.75 | 2,225 | $100K | 50.0% |
| Total | $44.75 avg | 4,450 | $199K | 100% |
| Filing → |
| DNLI | SELL | 2025-01-08 | $139K | — | Filing → |
| DNLI | SELL | 2025-01-03 | $608K | — | Filing → |
| DNLI | SELL | 2024-10-02 | $871K | — | Filing → |